Su-Jin Yoo

Prof. Su-Jin Yoo

Chungnam National University Hospital
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2022 in Science Signaling
Verified
Journal Article
Closed access
BKBonah Kim
Bonah Kim
HKHee Young Kim
Hee Young Kim
BYBo Ruem Yoon
Bo Ruem Yoon
JYJina Yeo
Jina Yeo
JJJi In Jung
Ji In Jung
WLWon-Woo Lee
Won-Woo Lee
Zinc metabolically reprograms monocytes and macrophages to promote inflammation in rheumatoid arthritis.

15 May 2020 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
HLHa-Reum Lee
Ha-Reum Lee
SYSu-Jin Yoo
Su-Jin Yoo
JKJinhyun Kim
Jinhyun Kim
IYIn Seol Yoo
In Seol Yoo
CPChan Keol Park
Chan Keol Park
SKSeong Wook Kang
Seong Wook Kang
Background: Reactive oxygen species (ROS) regulate the migration and invasion of fibroblast-like synoviocytes (FLS), which are key effector cells in rheumatoid arthritis (RA) pathogenesis. Nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4) induces ROS generation and, consequently, enhances cell migration. Despite the important interrelationship between RA, FLS, and ROS, the effect of NOX4 on RA pathogenesis remains unclear. Methods: FLS isolated from RA (n = 5) and osteoarthritis (OA, n = 5) patients were stimulated with recombinant interleukin 17 (IL-17; 10 ng/ml) and tumor necrosis factor alpha (TNF-α; 10 ng/ml) for 1 h. Cell migration, invasion, adhesion molecule expression, vascular endothelial growth factor (VEGF) secretion, and ROS expression were examined. The mRNA and protein levels of NOX4 were analyzed by RT-qPCR and western blotting, respectively. The NOX4 inhibitor GLX351322 and NOX4 siRNA were used to inhibit NOX4 to probe the effect of NOX4 on these cellular processes. Results: Migration of RA FLS was increased 2.48-fold after stimulation with IL-17 and TNF-α, while no difference was observed for OA FLS. ROS expression increased in parallel with invasiveness of FLS following cytokine stimulation. When the expression of NOX was examined, NOX4 was significantly increased by 9.73-fold in RA FLS compared to unstimulated FLS. Following NOX4 inhibition, cytokine-induced vascular cell adhesion molecule 1 (VCAM1), VEGF, and migration and invasion capacity of RA FLS were markedly decreased to unstimulated levels. Conclusion: NOX4 is a key contributor to cytokine-enhanced migration and invasion via modulation of ROS, VCAM1, and VEGF in RA FLS.

26 April 2023 in Cells
Verified
Journal Article
Open access
PDF file
HLHa-Reum Lee
Ha-Reum Lee
SYSu-Jin Yoo
Su-Jin Yoo
JKJinhyun Kim
Jinhyun Kim
SKSeong Wook Kang
Seong Wook Kang
Fibroblast-like synoviocytes (FLS) in rheumatoid arthritis (RA) patients have increased reactive oxygen species (ROS) levels and an impaired redox balance compared with FLS from control patients. Liver kinase B1 (LKB1) plays a key role in ROS scavenging and cellular metabolism in various cancers. Here, we aimed to determine the specific mechanism of LKB1 in RA pathogenesis. FLS were obtained from RA patients (n = 10). siRNA-induced LKB1 deficiency in RA FLS increased ROS levels via NADPH oxidase 4 (NOX4) upregulation. RA FLS migration and expression of inflammatory factors, including interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor-alpha (TNF-α), and vascular endothelial growth factor (VEGF), were enhanced by LKB1 deficiency. LKB1-deficient RA FLS showed increased sensitivity to oxidative stress damage caused by hydrogen peroxidase exposure. siRNA-induced solute carrier family 7 member 11 (SLC7A11) deficiency in RA FLS enhanced NOX4 and ROS expression and increased cell migration. When LKB1-deficient RA FLS were stimulated with an AMP-activated protein kinase (AMPK) activator, the LKB1-inhibition-induced cell migration significantly decreased through the restoration of SLC7A11/NOX4 expression. LKB1 regulates the AMPK-mediated SLC7A11-NOX4-ROS pathway to control cell migration and inflammation. Our data indicate that LKB1 is a key regulator of redox homeostasis in RA FLS.

Verified
Journal Article
Open access
PDF file
HLHa-Reum Lee
Ha-Reum Lee
SYSu-Jin Yoo
Su-Jin Yoo
JKJinhyun Kim
Jinhyun Kim
CPChan Keol Park
Chan Keol Park
SKSeong Wook Kang
Seong Wook Kang
The production and oxidation mechanism of reactive oxygen species (ROS) are out of balance in rheumatoid arthritis (RA). However, the correlation between ROS and T cell subsets in RA remains unclear. Peripheral blood mononuclear cells (PBMCs) from patients with RA (n = 40) and healthy controls (n = 10) were isolated from whole blood samples. Synovial tissues (n = 3) and synovial fluid (n = 10) were obtained from patients with RA. The repartition of T cell subsets and expression of ROS and cytokines were examined according to RA severity. Fibroblast-like synoviocytes (FLSs) from patients with RA were stimulated with PBMCs and the expression of inflammation-related molecules were measured by RT-PCR and cytokine array. Regulatory T cells from patients with moderate (5.1 > DAS28 ≥ 3.2) RA showed the highest expression of mitochondrial ROS among the groups based on disease severity. Although ROS levels steadily increased with RA severity, there was a slight decline in severe RA (DAS28 ≥ 5.1) compared with moderate RA. The expression of inflammatory cytokines in RA FLSs were significantly inhibited when FLSs were co-cultured with PBMCs treated with ROS inhibitor. These findings provide a novel approach to suppress inflammatory response of FLSs through ROS regulation in PBMCs.

3 April 2021 in Cells
Verified
Journal Article
Open access
PDF file
EGEunbyeol Go
Eunbyeol Go
SYSu-Jin Yoo
Su-Jin Yoo
Suyoung ChoiSuyoung Choi
Suyoung Choi
PSPureum Sun
Pureum Sun
MJMin Kyung Jung
Min Kyung Jung
Jaeyul KwonJaeyul Kwon
Jaeyul Kwon
Rheumatoid arthritis (RA) is a common autoimmune disease characterized by immune cell infiltration of the synovium, leading to the loss of cartilage, bone, and joint function. Although regulatory T (Treg) cells are thought to modulate the initiation and progression of RA, a consensus has yet to be reached regarding the function and composition of Treg cells in RA patients. To address these discrepancies, we analyzed not only the total Treg frequency but also that of Treg subpopulations in the peripheral blood of RA patients and healthy controls by flow cytometry. We found that the total Treg population was not significantly different between RA and control subjects. However, the effector Treg cell subgroup, defined as CD45RA−CD25hi, showed markedly decreased frequency in RA patients. In addition, the total Treg population from RA patients showed a significant decline in the expression of CD25. Both the naïve and effector Treg subgroups also showed marked reduction of CD25 expression in RA patients compared to controls. These data suggest that the decreased frequency of effector Treg cells and overall reduction of CD25 expression in Treg cells in the peripheral blood may be evidence of altered Treg homeostasis associated with RA pathogenesis.

20 July 2022 in Journal of Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
JKJihyoun Kim
Jihyoun Kim
JLJeong Seok Lee
Jeong Seok Lee
BCByoong Yong Choi
Byoong Yong Choi
CYCheon Yun-Hong
Cheon Yun-Hong
SYSu-Jin Yoo
Su-Jin Yoo
YLYun Jong Lee
Yun Jong Lee
Ji Hyoun Kim, M.D., Jeong Seok Lee, M.D., Ph.D., Byoong Yong Choi, M.D., Yun-Hong Cheon, M.D., Su-Jin Yoo, M.D., Ph.D., Ji Hyeon Ju, M.D., Ph.D., Kichul Shin, M.D., Ph.D., Eu Suk Kim, M.D., Ph.D., Han Joo Baek, M.D., Ph.D., Won Park, M.D., Ph.D., Yeong Wook Song, M.D., Ph.D., Woi-Hyun Hong, Ph.D., Yun Jong Lee, M.D., Ph.D.. J Rheum Dis 2022;29:243-53. https://doi.org/10.4078/jrd.22.0014